Is Legend Biotech’s Plunge a Buying Opportunity? The Numbers Don’t Lie
Stock News and Performance In a surprising turn of events, **Legend Biotech Corp** (LEGN) has seen its stock tumble by **5.01%**, settling at **$33.36** per share. The trading session recorded…